Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas

被引：0
|
作者：
Francoise Bouet-Toussaint
Florian Cabillic
Olivier Toutirais
Matthieu Le Gallo
Cécile Thomas de la Pintière
Pascale Daniel
Noëlle Genetet
Bernard Meunier
Eric Dupont-Bierre
Karim Boudjema
Véronique Catros
机构：
[1] UPRES EA 3891,Laboratoire de Cytogénétique et Biologie Cellulaire
[2] Faculté de Médecine de Rennes,Département de Chirurgie Viscérale
[3] CHU de Rennes,undefined
[4] CHU de Rennes,undefined
来源：
Cancer Immunology, Immunotherapy | 2008年 / 57卷
关键词：
Human; T cells; Cytotoxic; Cell activation; Tumor immunity; T Cell receptors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：531 / 539
页数：8
相关论文
共 50 条
  • [1] Vγ9Vδ2 T cell-mediated recognition of human solid tumors.: Potential for immunotherapy of hepatocellular and colorectal carcinomas
    Bouet-Toussaint, Francoise
    Cabillic, Florian
    Toutirais, Olivier
    Le Gallo, Matthieu
    de la Pintiere, Cecile Thomas
    Daniel, Pascale
    Genetet, Noelle
    Meunier, Bernard
    Dupont-Bierre, Eric
    Boudjema, Karim
    Catros, Veronique
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (04) : 531 - 539
  • [2] Sensing cell stress and transformation through Vγ9Vδ2 T cell-mediated recognition of the isoprenoid pathway metabolites
    Bonneville, M
    Fournié, JJ
    MICROBES AND INFECTION, 2005, 7 (03) : 503 - 509
  • [3] Human Vγ9Vδ2 T cells:: promising new leads for immunotherapy of infections and tumors
    Bonneville, Marc
    Scotet, Emmanuel
    CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (05) : 539 - 546
  • [4] Improving the Efficiency of Vγ9Vδ2 T Cell Immunotherapy in Cancer
    Hoeres, Timm
    Smetak, Manfred
    Pretscher, Dominik
    Wilhelm, Martin
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [5] Vγ9Vδ2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy
    Poccia, F
    Agrati, C
    Martini, F
    Mejia, G
    Wallace, M
    Malkovsky, M
    IMMUNOLOGY LETTERS, 2005, 100 (01) : 14 - 20
  • [6] Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody
    de Bruin, Renee C. G.
    Stam, Anita G. M.
    Vangone, Anna
    Henegouwen, Paul M. P. van Bergen en
    Verheul, Henk M. W.
    Sebestyen, Zsolt
    Kuball, Jurgen
    Bonvin, Alexandre M. J. J.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01): : 308 - 317
  • [7] Phosphoantigen recognition by Vγ9Vδ2 T cells
    Herrmann, Thomas
    Karunakaran, Mohindar Murugesh
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 (11)
  • [8] In vitro expansion of Vγ9Vδ2 T cells for immunotherapy
    Peters, Christian
    Kouakanou, Leonce
    Oberg, Hans-Heinrich
    Wesch, Daniela
    Kabelitz, Dieter
    TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - CELLULAR METHODS, PT A, 2020, 631 : 223 - 237
  • [9] RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
    Sebestyen, Zsolt
    Scheper, Wouter
    Vyborova, Anna
    Gu, Siyi
    Rychnavska, Zuzana
    Schiffler, Marleen
    Cleven, Astrid
    Cheneau, Coraline
    van Noorden, Martje
    Peigne, Cassie-Marie
    Olive, Daniel
    Lebbink, Robert Jan
    Oostvogels, Rimke
    Mutis, Tuna
    Schuurhuis, Gerrit Jan
    Adams, Erin J.
    Scotet, Emmanuel
    Kuball, Jurgen
    CELL REPORTS, 2016, 15 (09): : 1973 - 1985
  • [10] Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate
    Sugai, Shiori
    Yoshikawa, Toshiaki
    Iwama, Tatsuaki
    Tsuchiya, Nobuhiro
    Ueda, Norihiro
    Fujinami, Norihiro
    Shimomura, Manami
    Zhang, Rong
    Kaneko, Shin
    Uemura, Yasushi
    Nakatsura, Tetsuya
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (05) : 1794 - 1804
12345